You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Colorcon
Merck
Mallinckrodt
Baxter

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Caprylic alcohol


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Caprylic alcohol?

Caprylic alcohol is an investigational drug.

There have been 4 clinical trials for Caprylic alcohol. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.

The most common disease conditions in clinical trials are Peripheral Nervous System Diseases, Diabetic Neuropathies, and [disabled in preview]. The leading clinical trial sponsors are Accera, Inc., Celerion, and University of British Columbia.

There are three US patents protecting this investigational drug and thirty-three international patents.

Recent Clinical Trials for Caprylic alcohol
TitleSponsorPhase
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral NeuropathyUniversity of British ColumbiaPhase 1/Phase 2
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionCelerionPhase 1
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionAccera, Inc.Phase 1

See all Caprylic alcohol clinical trials

Clinical Trial Summary for Caprylic alcohol

Top disease conditions for Caprylic alcohol
Top clinical trial sponsors for Caprylic alcohol

See all Caprylic alcohol clinical trials

US Patents for Caprylic alcohol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Caprylic alcohol   Start Trial Cyanine compounds Pierce Biotechnology, Inc. (Rockford, IL) Dyomics GmbH (Jena, DE)   Start Trial
Caprylic alcohol   Start Trial Hydrosilylation reaction catalyst KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Fukuoka-Shi, JP) SHIN-ETSU CHEMICAL CO., LTD. (Tokyo, JP)   Start Trial
Caprylic alcohol   Start Trial Materials for organic electroluminescent devices Merck Patent GmbH (DE)   Start Trial
Caprylic alcohol   Start Trial Method for producing pyrrole derivative, and intermediate thereof Daiichi Sankyo Company, Limited (Chuo-ku, JP)   Start Trial
Caprylic alcohol   Start Trial Quaternary and cationic ammonium surfactants as corrosion inhibitors Ecolab USA Inc. (St. Paul, MN)   Start Trial
Caprylic alcohol   Start Trial Polyurethane fiber TORAY OPELONTEX CO., LTD. (Osaka, JP)   Start Trial
Caprylic alcohol   Start Trial Compounds for electronic devices Merck Patent Gmbh (Darmstadt, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Caprylic alcohol

Drugname Country Document Number Estimated Expiration Related US Patent
Caprylic alcohol China 104395306 2032-03-02   Start Trial
Caprylic alcohol European Patent Office 2804860 2032-03-02   Start Trial
Caprylic alcohol European Patent Office 3081564 2032-03-02   Start Trial
Caprylic alcohol World Intellectual Property Organization (WIPO) 2013130761 2032-03-02   Start Trial
Caprylic alcohol China 106660031 2034-08-12   Start Trial
Caprylic alcohol European Patent Office 3181226 2034-08-12   Start Trial
Caprylic alcohol Japan 6515930 2034-08-12   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
McKinsey
Moodys
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.